Global Allergy Treatment Market size was valued at USD 24.6 Bn. in 2024, and the total Allergy Treatment Market is expected to grow by 7.2 %. from 2025 to 2032, reaching nearly USD 42.9 Bn.Allergy Treatment Market Overview
The allergy treatment market comprises a wide range of products and therapies aimed at diagnosing, managing, and alleviating allergic conditions. This includes drugs such as antihistamines, corticosteroids, and biologics, as well as immunotherapies like allergy shots and sublingual tablets, alongside diagnostic tools and devices used across hospitals, clinics, and homecare settings.The Allergy Treatment Market is experiencing significant growth, driven by rising allergy prevalence, technological innovations, and shifting patient preferences. North America currently leads the market, supported by advanced treatment options, favorable reimbursement, and strong healthcare infrastructure. Meanwhile, Asia-Pacific is the fastest-growing region, fueled by urbanization, pollution, and rising disposable incomes in countries like India and China. While food and skin allergy treatments represent the fastest-growing segments, supported by changing dietary habits and heightened awareness. Innovation is a key driver, with advances in biologics, personalized medicine through gene profiling, and user-friendly diagnostic kits enhancing outcomes. Digital health tools, mobile apps, and telemedicine are further transforming patient engagement and access to care.To know about the Research Methodology :- Request Free Sample Report The FDA approval of omalizumab (Xolair) for food allergies and Beckman Coulter’s multiplex allergy assays, illustrate the sector’s rapid progress. Together, these factors position the market for robust growth, offering opportunities for global pharma leaders and specialty biotech firms alike.
Allergy Treatment Market Dynamics:
Rising Prevalence of Allergic Rhinitis & Asthma to drive the Allergy Treatment Market Environmental factors and urbanization are key contributors, as increasing air pollution in megacities from Beijing to Delhi triggers immune responses, raising the risk of these conditions. Sensitization rates in such cities exceed 50%, while globally, allergic rhinitis affects up to 30% of adults and 40% of children, creating a substantial and consistent patient base for allergy therapies. Climate change further intensifies demand, with longer pollen seasons and altered allergen distribution leading to more frequent and severe allergic episodes. Lifestyle changes, including increased indoor time and higher exposure to dust mites, pet dander, and pollutants, are also driving incidence rates. Genetic predisposition amplifies susceptibility, contributing to the overall market potential. Technological advancements like telemedicine, mobile symptom trackers, and digital health platforms are encouraging patients to seek treatment and adhere to therapy plans, expanding market reach. Globally, asthma prevalence varies significantly, from 3.3% in Pakistan to 14.3% in Saudi Arabia, while urban pollution in cities like Beijing has increased asthma rates from 11.1% to 17.6% in six years. This growing patient population, coupled with the availability of over-the-counter drugs, second-generation antihistamines, and innovative biologics such as omalizumab, is boosting market demand. Rising healthcare costs and productivity losses also motivate governments and patients to adopt better treatment options. The escalating prevalence of asthma and allergic rhinitis is a major driver of the global allergy treatment market. Expanding R&D and Innovative Therapies creates growth opportunities in Allergy Treatment Market The increasing focus on research and development in allergy treatments is creating significant growth opportunities in the global allergy treatment market. Researchers are exploring diverse approaches, including allergen immunotherapy, DNA- and virus-such as particle-based vaccines, biologics such as anti-IgE antibodies, and advanced cell and gene therapies. Rising adoption of biologics and regenerative medicine provides new pathways for innovative drug development. Investment in R&D is accelerating through public-private partnerships and increased funding, driving advancements in both treatment efficacy and patient accessibility. Tele-immunotherapy has emerged as a transformative channel, increasing from 17% usage before the pandemic to 89% during lockdowns, signaling a long-term shift in treatment delivery. Advanced technologies, such as AI-based allergen and pollen forecasting, enable real-time dose titration, enhancing safety and treatment outcomes. Sublingual immunotherapy (SLIT) tablets have gained traction due to their comparable efficacy with subcutaneous injections, fewer injection-site reactions, and improved patient compliance. Inclusion in pharmacy-benefit listings further reduces barriers, increasing accessibility. These developments in R&D, digital health integration, and patient-friendly therapies are driving incremental market growth, positioning the global allergy treatment market for sustained growth and innovation.Allergy Treatment Market Segment Analysis:
Based On Allergy Type, Allergy Treatment Market is segmented into Eye Allergy, Rhinitis Asthma, Skin Allergy, Food Allergy and Other Allergies. The rhinitis segment dominated the Allergy Type segment in 2024. Due to high prevalence and growing patient awareness. Allergic rhinitis, caused by airborne allergens such as pollen, dust mites, and pet dander, affects millions worldwide, particularly in urbanized regions with rising pollution levels. Sensitization rates in key cities often exceed 50%, creating a large and consistent patient base for treatments. Environmental factors, including air pollution, climate change, and longer pollen seasons, have intensified symptom frequency and severity, boosting demand for both prescription and over-the-counter therapies. Advances in treatment options, such as second-generation antihistamines, intranasal corticosteroids, and sublingual immunotherapy (SLIT), have improved efficacy and patient compliance, making management easier and more effective. Increasing digital health adoption, telemedicine consultations, and public awareness campaigns have facilitated early diagnosis and treatment initiation. Together, these factors contribute to the rhinitis segment’s dominant market share, reflecting both the widespread impact of the condition and growing therapeutic adoption globally.Based on End User, Allergy Treatment Market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Retailers, Others. The Hospital Pharmacies segment dominated the End User segment in 2024.Due to its critical role in providing specialized care and access to advanced allergy therapies. Hospitals are primary points for diagnosis, treatment initiation, and management of moderate-to-severe allergic conditions such as asthma, rhinitis, and skin allergies. This ensures a steady and substantial demand for prescription medications, biologics, and immunotherapy treatments. The presence of trained healthcare professionals enables accurate prescription, monitoring, and patient education, which is particularly important for complex treatments like biologics and subcutaneous or sublingual immunotherapy. Additionally, hospital pharmacies often have established supply chains, bulk procurement advantages, and partnerships with pharmaceutical manufacturers, ensuring consistent availability of allergy medications. Rising patient awareness, increasing prevalence of chronic allergies, and the growing adoption of hospital-based specialty treatments further reinforce the dominance of hospital pharmacies. Their capacity to deliver both emergency and routine allergy care makes them the most preferred and trusted channel in the Allergy Treatment Market.
Allergy Treatment Market Regional Analysis:
North America dominated the Allergy Treatment Market in 2024. This leadership is driven by strong economic, clinical, and regulatory factors that enable wider patient access and early adoption of advanced therapies. Extensive insurance coverage in the U.S. and Canada supports diagnostics, prescription medications, immunotherapies, and biologics, facilitating high patient uptake. Early adoption of novel therapies has positioned North America as a global launch hub. The FDA approved omalizumab (Xolair) for multiple food allergies and Palforzia, the first oral peanut allergy immunotherapy, in 2024, enabling immediate clinical rollout across hospitals and specialty clinics. Concentrated networks of allergists and immunologists ensure precise diagnostics, personalized treatments, and management of severe allergic conditions such as asthma and rhinitis. Technological innovations and digital health integration further strengthen the market. Multiplex allergy assays and AI-driven pollen forecasting streamline diagnosis and optimize dosing, while EHR-integrated platforms and tele-immunotherapy improve patient adherence and outcomes. Strategic partnerships between biotech firms have accelerated the development of oral mucosal immunotherapies and advanced biologics, particularly for complex allergies. Public awareness campaigns, advocacy by organizations like the Asthma and Allergy Foundation of America, and patient-driven demand for personalized therapies reinforce high adoption rates. Combined with a regional market valuation surpassing $10.88 billion in the U.S., these factors underscore North America’s leadership in advancing allergy treatment accessibility, innovation, and clinical outcomes globally. Allergy Treatment Market Competitive Analysis: The global allergy treatment market in 2024 is highly fragmented, with strong competition between pharmaceutical giants and specialized biotech firms. Major players include Johnson & Johnson, Sanofi, GSK, Novartis, Pfizer, Teva, AbbVie, Bayer, AstraZeneca, and Roche, alongside niche innovators such as ALK-Abelló, Stallergenes Greer, and Allergy Therapeutics. These companies lead across key segments including anti-allergy drugs, immunotherapy, food allergy treatments, and diagnostics.Anti-allergy drugs remain the largest revenue driver, dominated by firms like Sanofi, GSK, and Novartis, while immunotherapy specialists ALK-Abelló and Stallergenes Greer pioneer SLIT tablets and oral immunotherapy. Food allergy treatments are gaining traction with Palforzia and multi-allergen biologics like omalizumab. Diagnostics leaders such as Thermo Fisher and Beckman Coulter are enhancing patient care through multiplex assays and digital platforms. Key trends shaping competition include aggressive R&D partnerships, biosimilar launches, device innovation (e.g., nasal epinephrine sprays), and digital differentiation. With diversified portfolios and strong pipelines, leading companies continue to expand global access, driving market growth Allergy Treatment Market Key Trends: 1. Rise of Biologics and Targeted Immunotherapies Biologics, such as anti-IgE antibodies, and advanced immunotherapy options are transforming allergy management. These therapies target specific immune pathways, offering effective treatment for severe or persistent allergic conditions like asthma, rhinitis, and food allergies. Increased FDA approvals, growing clinical adoption, and expanding patient access are driving market growth, with hospitals and specialty clinics leading the uptake. 2. Digital Health Integration and Telemedicine Expansion The adoption of digital health tools, including tele-immunotherapy, AI-based allergen forecasting, mobile symptom trackers, and EHR-integrated platforms, is enhancing patient monitoring, adherence, and real-time dose adjustments. Telemedicine usage surged during the COVID-19 pandemic, shifting long-term treatment delivery toward remote and hybrid care models. This trend improves patient convenience, reduces healthcare costs, and expands reach in underserved regions, creating a significant growth avenue for the allergy treatment market. Allergy Treatment Market Key Development: May 16, 2024, Johnson & Johnson acquire Proteologix, Inc. for $850 million, plus potential milestones, strengthening its immunology pipeline with bispecific antibodies for atopic dermatitis (AD) and asthma. Key assets include PX128, entering Phase 1, and PX130 in preclinical development. The acquisition expands J&J’s innovative therapies targeting multiple pathways to achieve durable remission in immune-mediated diseases. July 31,2025, Allergy Therapeutics, a fully integrated commercial biotechnology company focused on allergy immunotherapies, announced the publication of three key studies in Allergy, the official EAACI journal with an impact factor of 12.6. The publications highlight the efficacy, safety, and quality-of-life benefits of Grass MATA MPL, the company’s innovative SCIT candidate for grass pollen-induced allergic rhinoconjunctivitis. June 2, 2025, Sanofi will acquire Blueprint Medicines for $9.1 billion, with potential milestone payments raising the deal to $9.5 billion. The acquisition adds Ayvakit/Ayvakyt, the only approved therapy for advanced and indolent systemic mastocytosis, alongside elenestinib and BLU-808. This strengthens Sanofi’s immunology portfolio and expands its presence in rare immunological diseases through Blueprint’s established specialist network. April 23, 2025 ALK has received European approval for ITULAZAX, its tree pollen sublingual allergy tablet, for children and adolescents aged 5–17 across 17 EU countries. Based on positive Phase 3 TT-06 trial results, the approval expands ALK’s immunotherapy portfolio, now covering five major respiratory allergies across all age groups in key global markets.Allergy Treatment Market Scope: Inquire before buying
Global Allergy Treatment Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 24.6 Bn. Forecast Period 2025 to 2032 CAGR: 7.2% Market Size in 2032: USD 42.9 Bn. Segments Covered: by Allergy Type Eye Allergy Rhinitis Asthma Skin Allergy Food Allergy Other Allergies by Treatment Type Anti-allergy drugs Antihistamines Corticosteroids Decongestants Other drugs Immunotherapy Sub-cutaneous immunotherapy (SCIT) Sub-lingual immunotherapy (SLIT) by Route of Administration Oral Inhalers Intranasal Others by Dosage Form Tablets & Capsules Nasal Sprays Others by End User Hospital Pharmacies Retail Pharmacies Online Retailers Others Allergy Treatment Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) South America (Brazil, Argentina Rest of South America) Middle East & Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)Allergy Treatment Key players
North America 1. AbbVie Inc. (US) 2. Johnson & Johnson Services, Inc. (US) 3. Stallergenes Greer (US) 4. Genentech (US) 5. Inimmune Corporation (US) 6. Intrommune Therapeutics (US) 7. Perrigo Company plc (US) 8. Regeneron Pharmaceuticals (US) Europe 9. GlaxoSmithKline plc (GSK) (UK) 10. Allergy Therapeutics plc (UK) 11. ALK-Abelló A/S (Denmark) 12. Allergopharma (Dermapharm AG) (Germany) 13. Bayer AG (Germany) 14. Boehringer Ingelheim International GmbH (Germany) 15. HAL Allergy Group (Netherlands) 16. Leti Pharma (Spain) 17. AstraZeneca plc (UK) 18. Biomay AG (Austria) 19. Circassia Group plc (UK) 20. ASIT Biotech (Belgium) 21. Anergis SA (Switzerland) 22. DBV Technologies (France) 23. Aimmune Therapeutics (US) 24. Immunomic Therapeutics (US) 25. Nicox S.A. (France) 26. Sanofi S.A. (France)Allergy Treatment Market Frequently Asked Questions
1. Market Size of Allergy Treatment Market? Ans: Global Allergy Treatment Market size was valued at USD 24.6 Bn. in 2024, and the total Allergy Treatment Market is expected to grow by 7.2 %. from 2025 to 2032, reaching nearly USD 42.9 Bn. 2. Which region dominated the Allergy Treatment Market? Ans: North America is the region that dominates the Allergy Treatment Market. 3. What is the study period of this market? Ans: The Allergy Treatment Market is studied from 2024 to 2032. 4.Who are the primary end users in the allergy treatment market? Ans: Hospital Pharmacies, Retail Pharmacies, Online Retailers, Others, are the End Users of the Allergy Treatment Market.
1. Allergy Treatment Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Allergy Treatment Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Allergy Treatment Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Allergy Treatment Market: Dynamics 3.1. Allergy Treatment Market Trends by Region 3.1.1. North America Allergy Treatment Market Trends 3.1.2. Europe Allergy Treatment Market Trends 3.1.3. Asia Pacific Allergy Treatment Market Trends 3.1.4. Middle East and Africa Allergy Treatment Market Trends 3.1.5. South America Allergy Treatment Market Trends 3.2. Allergy Treatment Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Allergy Treatment Market Drivers 3.2.1.2. North America Allergy Treatment Market Restraints 3.2.1.3. North America Allergy Treatment Market Opportunities 3.2.1.4. North America Allergy Treatment Market Challenges 3.2.2. Europe 3.2.2.1. Europe Allergy Treatment Market Drivers 3.2.2.2. Europe Allergy Treatment Market Restraints 3.2.2.3. Europe Allergy Treatment Market Opportunities 3.2.2.4. Europe Allergy Treatment Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Allergy Treatment Market Drivers 3.2.3.2. Asia Pacific Allergy Treatment Market Restraints 3.2.3.3. Asia Pacific Allergy Treatment Market Opportunities 3.2.3.4. Asia Pacific Allergy Treatment Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Allergy Treatment Market Drivers 3.2.4.2. Middle East and Africa Allergy Treatment Market Restraints 3.2.4.3. Middle East and Africa Allergy Treatment Market Opportunities 3.2.4.4. Middle East and Africa Allergy Treatment Market Challenges 3.2.5. South America 3.2.5.1. South America Allergy Treatment Market Drivers 3.2.5.2. South America Allergy Treatment Market Restraints 3.2.5.3. South America Allergy Treatment Market Opportunities 3.2.5.4. South America Allergy Treatment Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Allergy Treatment Industry 3.8. Analysis of Government Schemes and Initiatives For Allergy Treatment Industry 3.9. Allergy Treatment Market Trade Analysis 3.10. The Global Pandemic Impact on Allergy Treatment Market 4. Allergy Treatment Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 4.1.1. Eye Allergy 4.1.2. Rhinitis 4.1.3. Asthma 4.1.4. Skin Allergy 4.1.5. Food Allergy 4.1.6. Other Allergies 4.2. Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 4.2.1. Anti-allergy drugs 4.2.2. Immunotherapy 4.3. Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 4.3.1. Oral 4.3.2. Inhalers 4.3.3. Intranasal 4.3.4. Others 4.4. Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 4.4.1. Tablets & Capsules 4.4.2. Nasal Sprays 4.4.3. Others 4.5. Allergy Treatment Market Size and Forecast, by End User (2024-2032) 4.5.1. Hospital Pharmacies 4.5.2. Retail Pharmacies 4.5.3. Online Retailers 4.5.4. Others 4.6. Allergy Treatment Market Size and Forecast, by Region (2024-2032) 4.6.1. North America 4.6.2. Europe 4.6.3. Asia Pacific 4.6.4. Middle East and Africa 4.6.5. South America 5. North America Allergy Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 5.1.1. Eye Allergy 5.1.2. Rhinitis 5.1.3. Asthma 5.1.4. Skin Allergy 5.1.5. Food Allergy 5.1.6. Other Allergies 5.2. North America Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 5.2.1. Anti-allergy drugs 5.2.2. Immunotherapy 5.3. North America Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 5.3.1. Oral 5.3.2. Inhalers 5.3.3. Intranasal 5.3.4. Others 5.4. North America Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 5.4.1. Tablets & Capsules 5.4.2. Nasal Sprays 5.4.3. Others 5.5. North America Allergy Treatment Market Size and Forecast, by End User (2024-2032) 5.5.1. Hospital Pharmacies 5.5.2. Retail Pharmacies 5.5.3. Online Retailers 5.5.4. Others 5.6. North America Allergy Treatment Market Size and Forecast, by Country (2024-2032) 5.6.1. United States 5.6.1.1. United States Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 5.6.1.1.1. Eye Allergy 5.6.1.1.2. Rhinitis 5.6.1.1.3. Asthma 5.6.1.1.4. Skin Allergy 5.6.1.1.5. Food Allergy 5.6.1.1.6. Other Allergies 5.6.1.2. United States Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 5.6.1.2.1. Anti-allergy drugs 5.6.1.2.2. Immunotherapy 5.6.1.3. United States Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 5.6.1.3.1. Oral 5.6.1.3.2. Inhalers 5.6.1.3.3. Intranasal 5.6.1.3.4. Others 5.6.1.4. United States Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 5.6.1.4.1. Tablets & Capsules 5.6.1.4.2. Nasal Sprays 5.6.1.4.3. Others 5.6.1.5. United States Allergy Treatment Market Size and Forecast, by End User (2024-2032) 5.6.1.5.1. Hospital Pharmacies 5.6.1.5.2. Retail Pharmacies 5.6.1.5.3. Online Retailers 5.6.1.5.4. Others 5.6.2. Canada 5.6.2.1. Canada Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 5.6.2.1.1. Eye Allergy 5.6.2.1.2. Rhinitis 5.6.2.1.3. Asthma 5.6.2.1.4. Skin Allergy 5.6.2.1.5. Food Allergy 5.6.2.1.6. Other Allergies 5.6.2.2. Canada Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 5.6.2.2.1. Anti-allergy drugs 5.6.2.2.2. Immunotherapy 5.6.2.3. Canada Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 5.6.2.3.1. Oral 5.6.2.3.2. Inhalers 5.6.2.3.3. Intranasal 5.6.2.3.4. Others 5.6.2.4. Canada Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 5.6.2.4.1. Tablets & Capsules 5.6.2.4.2. Nasal Sprays 5.6.2.4.3. Others 5.6.2.5. Canada Allergy Treatment Market Size and Forecast, by End User (2024-2032) 5.6.2.5.1. Hospital Pharmacies 5.6.2.5.2. Retail Pharmacies 5.6.2.5.3. Online Retailers 5.6.2.5.4. Others 5.6.3. Mexico 5.6.3.1. Mexico Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 5.6.3.1.1. Eye Allergy 5.6.3.1.2. Rhinitis 5.6.3.1.3. Asthma 5.6.3.1.4. Skin Allergy 5.6.3.1.5. Food Allergy 5.6.3.1.6. Other Allergies 5.6.3.2. Mexico Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 5.6.3.2.1. Anti-allergy drugs 5.6.3.2.2. Immunotherapy 5.6.3.3. Mexico Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 5.6.3.3.1. Oral 5.6.3.3.2. Inhalers 5.6.3.3.3. Intranasal 5.6.3.3.4. Others 5.6.3.4. Mexico Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 5.6.3.4.1. Tablets & Capsules 5.6.3.4.2. Nasal Sprays 5.6.3.4.3. Others 5.6.3.5. Mexico Allergy Treatment Market Size and Forecast, by End User (2024-2032) 5.6.3.5.1. Hospital Pharmacies 5.6.3.5.2. Retail Pharmacies 5.6.3.5.3. Online Retailers 5.6.3.5.4. Others 6. Europe Allergy Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.2. Europe Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.3. Europe Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.4. Europe Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.5. Europe Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6. Europe Allergy Treatment Market Size and Forecast, by Country (2024-2032) 6.6.1. United Kingdom 6.6.1.1. United Kingdom Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.1.2. United Kingdom Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.1.3. United Kingdom Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.1.4. United Kingdom Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.1.5. United Kingdom Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.2. France 6.6.2.1. France Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.2.2. France Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.2.3. France Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.2.4. France Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.2.5. France Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.3. Germany 6.6.3.1. Germany Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.3.2. Germany Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.3.3. Germany Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.3.4. Germany Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.3.5. Germany Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.4. Italy 6.6.4.1. Italy Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.4.2. Italy Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.4.3. Italy Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.4.4. Italy Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.4.5. Italy Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.5. Spain 6.6.5.1. Spain Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.5.2. Spain Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.5.3. Spain Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.5.4. Spain Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.5.5. Spain Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.6. Sweden 6.6.6.1. Sweden Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.6.2. Sweden Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.6.3. Sweden Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.6.4. Sweden Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.6.5. Sweden Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.7. Austria 6.6.7.1. Austria Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.7.2. Austria Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.7.3. Austria Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.7.4. Austria Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.7.5. Austria Allergy Treatment Market Size and Forecast, by End User (2024-2032) 6.6.8. Rest of Europe 6.6.8.1. Rest of Europe Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 6.6.8.2. Rest of Europe Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 6.6.8.3. Rest of Europe Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 6.6.8.4. Rest of Europe Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 6.6.8.5. Rest of Europe Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7. Asia Pacific Allergy Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.2. Asia Pacific Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.3. Asia Pacific Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.4. Asia Pacific Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.5. Asia Pacific Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6. Asia Pacific Allergy Treatment Market Size and Forecast, by Country (2024-2032) 7.6.1. China 7.6.1.1. China Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.1.2. China Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.1.3. China Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.1.4. China Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.1.5. China Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.2. S Korea 7.6.2.1. S Korea Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.2.2. S Korea Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.2.3. S Korea Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.2.4. S Korea Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.2.5. S Korea Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.3. Japan 7.6.3.1. Japan Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.3.2. Japan Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.3.3. Japan Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.3.4. Japan Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.3.5. Japan Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.4. India 7.6.4.1. India Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.4.2. India Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.4.3. India Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.4.4. India Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.4.5. India Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.5. Australia 7.6.5.1. Australia Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.5.2. Australia Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.5.3. Australia Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.5.4. Australia Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.5.5. Australia Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.6. Indonesia 7.6.6.1. Indonesia Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.6.2. Indonesia Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.6.3. Indonesia Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.6.4. Indonesia Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.6.5. Indonesia Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.7. Malaysia 7.6.7.1. Malaysia Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.7.2. Malaysia Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.7.3. Malaysia Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.7.4. Malaysia Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.7.5. Malaysia Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.8. Vietnam 7.6.8.1. Vietnam Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.8.2. Vietnam Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.8.3. Vietnam Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.8.4. Vietnam Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.8.5. Vietnam Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.9. Taiwan 7.6.9.1. Taiwan Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.9.2. Taiwan Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.9.3. Taiwan Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.9.4. Taiwan Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.9.5. Taiwan Allergy Treatment Market Size and Forecast, by End User (2024-2032) 7.6.10. Rest of Asia Pacific 7.6.10.1. Rest of Asia Pacific Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 7.6.10.2. Rest of Asia Pacific Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 7.6.10.3. Rest of Asia Pacific Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 7.6.10.4. Rest of Asia Pacific Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 7.6.10.5. Rest of Asia Pacific Allergy Treatment Market Size and Forecast, by End User (2024-2032) 8. Middle East and Africa Allergy Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 8.2. Middle East and Africa Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 8.3. Middle East and Africa Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 8.4. Middle East and Africa Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 8.5. Middle East and Africa Allergy Treatment Market Size and Forecast, by End User (2024-2032) 8.6. Middle East and Africa Allergy Treatment Market Size and Forecast, by Country (2024-2032) 8.6.1. South Africa 8.6.1.1. South Africa Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 8.6.1.2. South Africa Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 8.6.1.3. South Africa Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 8.6.1.4. South Africa Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 8.6.1.5. South Africa Allergy Treatment Market Size and Forecast, by End User (2024-2032) 8.6.2. GCC 8.6.2.1. GCC Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 8.6.2.2. GCC Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 8.6.2.3. GCC Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 8.6.2.4. GCC Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 8.6.2.5. GCC Allergy Treatment Market Size and Forecast, by End User (2024-2032) 8.6.3. Nigeria 8.6.3.1. Nigeria Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 8.6.3.2. Nigeria Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 8.6.3.3. Nigeria Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 8.6.3.4. Nigeria Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 8.6.3.5. Nigeria Allergy Treatment Market Size and Forecast, by End User (2024-2032) 8.6.4. Rest of ME&A 8.6.4.1. Rest of ME&A Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 8.6.4.2. Rest of ME&A Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 8.6.4.3. Rest of ME&A Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 8.6.4.4. Rest of ME&A Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 8.6.4.5. Rest of ME&A Allergy Treatment Market Size and Forecast, by End User (2024-2032) 9. South America Allergy Treatment Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 9.2. South America Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 9.3. South America Allergy Treatment Market Size and Forecast, by Route of Administration(2024-2032) 9.4. South America Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 9.5. South America Allergy Treatment Market Size and Forecast, by End User (2024-2032) 9.6. South America Allergy Treatment Market Size and Forecast, by Country (2024-2032) 9.6.1. Brazil 9.6.1.1. Brazil Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 9.6.1.2. Brazil Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 9.6.1.3. Brazil Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 9.6.1.4. Brazil Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 9.6.1.5. Brazil Allergy Treatment Market Size and Forecast, by End User (2024-2032) 9.6.2. Argentina 9.6.2.1. Argentina Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 9.6.2.2. Argentina Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 9.6.2.3. Argentina Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 9.6.2.4. Argentina Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 9.6.2.5. Argentina Allergy Treatment Market Size and Forecast, by End User (2024-2032) 9.6.3. Rest Of South America 9.6.3.1. Rest Of South America Allergy Treatment Market Size and Forecast, by Allergy Type (2024-2032) 9.6.3.2. Rest Of South America Allergy Treatment Market Size and Forecast, by Treatment Type (2024-2032) 9.6.3.3. Rest Of South America Allergy Treatment Market Size and Forecast, by Route of Administration (2024-2032) 9.6.3.4. Rest Of South America Allergy Treatment Market Size and Forecast, by Dosage Form (2024-2032) 9.6.3.5. Rest Of South America Allergy Treatment Market Size and Forecast, by End User (2024-2032) 10. Company Profile: Key Players 10.1. AbbVie Inc. (US) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Johnson & Johnson Services, Inc. (US) 10.3. Stallergenes Greer (US) 10.4. Genentech (US) 10.5. Inimmune Corporation (US) 10.6. Intrommune Therapeutics (US) 10.7. Perrigo Company plc (US) 10.8. Regeneron Pharmaceuticals (US) 10.9. GlaxoSmithKline plc (GSK) (UK) 10.10. Allergy Therapeutics plc (UK) 10.11. ALK-Abelló A/S (Denmark) 10.12. Allergopharma (Dermapharm AG) (Germany) 10.13. Bayer AG (Germany) 10.14. Boehringer Ingelheim International GmbH (Germany) 10.15. HAL Allergy Group (Netherlands) 10.16. Leti Pharma (Spain) 10.17. AstraZeneca plc (UK) 10.18. Biomay AG (Austria) 10.19. Circassia Group plc (UK) 10.20. ASIT Biotech (Belgium) 10.21. Anergis SA (Switzerland) 10.22. DBV Technologies (France) 10.23. Aimmune Therapeutics (US) 10.24. Immunomic Therapeutics (US) 10.25. Nicox S.A. (France) 10.26. Sanofi S.A. (France) 11. Key Findings 12. Industry Recommendations 13. Allergy Treatment Market: Research Methodology 14. Terms and Glossary
